Capricor Therapeutics Inc (CAPR)
EBITDA Growth
1103.57%
Quarterly · Period ending:
CAPR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported1103.57%period ending
Latest reported1103.57%period ending
CAPR Quarterly EBITDA YoY % (168.13% → 1103.57%)
Year-over-year change
High-resolution chart · PNG
CAPR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 1,103.5746% | |
| -39.2749% | |
| 14,582.3406% | |
| -97.4155% | |
| -138.8883% | |
| -153.4819% | |
| -1,383.2079% | |
| -99.4649% | |
| -49.6489% | |
| -25.5301% | |
| 93.9638% | |
| 1.9241% | |
| -1.636% | |
| 2.4262% | |
| -23.1914% | |
| -61.2089% | |
| -49.0054% | |
| -51.1579% | |
| -47.6848% | |
| 0.2782% | |
| -35.9129% | |
| -146.3663% | |
| -187.262% | |
| -144.661% | |
| -70.7962% | |
| 17.4808% | |
| 55.2173% | |
| 61.6316% | |
| 50.9457% | |
| 31.161% | |
| -125.9018% | |
| -59.2521% | |
| -23.881% | |
| -3.6617% | |
| 383.4909% | |
| 50.192% | |
| 27.2827% | |
| 15.4953% | |
| -34.7614% | |
| -84.6154% | |
| -50.8402% | |
| -22.9794% | |
| -75.3506% | |
| -91.644% | |
| -106.6031% | |
| -187.5318% | |
| 75.3948% | |
| 2.8646% | |
| 8.7761% | |
| 16.1975% | |
| -3,657.3177% | |
| -168.3172% | |
| -480.646% | |
| -82.6913% | |
| 87.941% | |
| 50.5444% | |
| 148.1834% | |
| 35.5577% | |
| -59.7502% | |
| 36.9061% | |
| 41.3885% | |
| 38.179% | |
| 32.7085% | |
| 9.0909% | |
| 39.4503% | |
| -12.9749% | |
| 47.9125% | |
| 40.4783% | |
| 35.2356% | |
| 45.717% | |
| -9.8373% | |
| 27.8003% | |
| -168.1103% | |
| -342.7072% | |
| -29,419.6507% | |
| -490.1887% | |
| -15,887.1136% | |
| -9,736.7367% | |
| -29.3603% | |
| -22,726.403% | |
| 406.2436% | |
| -34.1861% | |
| 30.4215% | |
| 2.2456% | |
| -2.4687% | |
| -118.0275% | |
| -88.8126% | |
| -4,138.5542% | |
| 58.7256% | |
| 33.4409% | |
| -42.895% | |
| 99.0307% | |
| 40.1323% | |
| -160.0194% | |
| -33.2862% | |
| -80.654% | |
| -109.3345% | |
| 168.1298% |